• Aucun résultat trouvé

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

N/A
N/A
Info
Télécharger
Protected

Academic year: 2021

Partager "Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion"

Copied!
7
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

Loading

Figure

Figure 1. High-resolution analysis of the del(13q14.3). Ideogram of chromosome 13 with a zoom on 4 Mb encompassing RB1, MIR15A/MIR16 and DLEU7.
Table 1. Clinical characteristics according to the presence of del(13q143)
Table 2. Deregulated pathways in diffuse large B-cell lymphomas with del(13q14.3) based upon Gene Set Enrichment Analysis
Figure 4. Frequency of DNA gains and losses observed in 166 diffuse large B-cell lymphomas patients according to the presence of del(14q14.3)

Références

Télécharger maintenant ( PDF - 7 Page - 529.47 KB )

Documents relatifs

Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas

Inhibition of Trk activation by K252a was confirmed in cell lines as shown in Figure 3A, for SUDHL4 and OCI-LY10, by the reduced phosphorylation of TrkB (Y817) as well as TrkA

Joyeuses Fêtes et Bonne Année

Tous se dépensent sans compter Et Jeanne Beuret va encore plus loin, associe l’en- semble des collaborateurs et de la classe politique à la bonne marche de la Cité. «Il faut

Premières Synthèses 2005-17.3 - Les difficultés des étrangers sur le marché du travail : effet nationalité, effet quartier? (PDF, 300.09 Ko)

(*) - Le risque relatif de chômage mesure le rapport entre la probabilité d'être au chômage et la probabilité d'être en emploi par rapport à une situation de référence : celle

Vue de Le rôle de l’huile de poisson en alimentation parentérale pédiatrique

En alimentation parentérale pédiatrique, il semble donc préférable d’utiliser l’huile de poisson pour le trai- tement de la cholestase associée à l’alimentation paren- térale

MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia

To identify miRNA with potential clinical applications, we initially profiled miRNA spectra from nine pooled samples including pooled healthy control, six pooled CLL samples based

R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL)

New England Journal of Medicine 2005;35212:1197-1205 7 Horning SJ, Weller E, Kim K, et al: Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive

Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles

We also used Affymetrix gene expression data available for part of Chapuy and colleagues’ cohort [21] and were able to reproduce the negative prognostic impact of high compo- nent

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study

Diffuse Large B Cell Lymphoma (DLBCL) by identifying recurrent somatic mutations.. We